Two-dimensional similarity between forms I and II of cytenamide, a carbamazepine analogue

被引：21

作者：

Florence, A. J. ^{[1
]}

Bedford, C. T. ^{[2
]}

Fabbiani, F. P. A. ^{[3
]}

Shankland, K. ^{[3
]}

Gelbrich, T. ^{[4
]}

Hursthouse, M. B. ^{[4
]}

Shankland, N. ^{[1
]}

Johnston, A. ^{[1
]}

Fernandes, P. ^{[1
]}

机构：

[1] Univ Strathclyde, Solid State Res Grp, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland

[2] UCL, Dept Chem, London WC1H 0AJ, England

[3] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England

[4] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England

来源：

CRYSTENGCOMM | 2008年 / 10卷 / 07期

基金：

英国工程与自然科学研究理事会;

关键词：

D O I：

10.1039/b719717a

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Cytenamide form I (R (3) over bar) undergoes a solid-state transformation upon heating to form II (P (1) over bar), with the structures exhibiting the same two-dimensional similarity that exists between the R (3) over bar and P (1) over bar forms of carbamazepine.

引用

页码：811 / 813

页数：3

共 27 条

[1] X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE [J].

BANDOLI, G ;

NICOLINI, M ;

ONGARO, A ;

VOLPE, G ;

RUBELLO, A .

JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1992, 22 (02) :177-183

[2] Solvent inclusion in form II carbamazepine [J].

Cabeza, Aurora J. Cruz ;

Day, Graeme M. ;

Motherwell, W. D. Samuel ;

Jones, William .

CHEMICAL COMMUNICATIONS, 2007, (16) :1600-1602

[3]

Coelho A., 2003, TOPAS USER MANUAL

[4] Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules [J].

Cruz Cabeza, Aurora J. ;

Day, Graeme M. ;

Motherwell, W. D. Samuel ;

Jones, William .

CRYSTAL GROWTH & DESIGN, 2007, 7 (01) :100-107

[5] Amide pyramidalization in carbamazepine: A flexibility problem in crystal structure prediction? [J].

Cruz Cabeza, Aurora J. ;

Day, Graeme M. ;

Motherwell, W. D. Samuel ;

Jones, William .

CRYSTAL GROWTH & DESIGN, 2006, 6 (08) :1858-1866

[6] Routine determination of molecular crystal structures from powder diffraction data [J].

David, WIF ;

Shankland, K ;

Shankland, N .

CHEMICAL COMMUNICATIONS, 1998, (08) :931-932

[7] DASH:: a program for crystal structure determination from powder diffraction data [J].

David, William I. F. ;

Shankland, Kenneth ;

van de Streek, Jacco ;

Pidcock, Elna ;

Motherwell, W. D. Samuel ;

Cole, Jason C. .

JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2006, 39 :910-915

[8] ANTICONVULSANTS .1. DIBENZO(A,D)CYCLOHEPTADIENE-5-CARBOXAMIDE + RELATED COMPOUNDS [J].

DAVIS, MA ;

THOMAS, RA ;

HERR, F ;

CHAREST, MP ;

WINTHROP, O ;

GAUDRY, R .

JOURNAL OF MEDICINAL CHEMISTRY, 1964, 7 (01) :88-&

[9] Solvent inclusion in the structural voids of form II carbamazepine: single-crystal X-ray diffraction, NMR spectroscopy and Hirshfeld surface analysis [J].

Fabbiani, Francesca P. A. ;

Byrne, Lindsay T. ;

McKinnon, Joshua J. ;

Spackman, Mark A. .

CRYSTENGCOMM, 2007, 9 (09) :728-731

[10] Solving molecular crystal structures from X-ray powder diffraction data:: The challenges posed by γ-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate [J].

Fernandes, Philippe ;

Shankland, Kenneth ;

Florence, Alastair J. ;

Shankland, Norman ;

Johnston, Andrea .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) :1192-1202

← 1 2 3 →